Morphological behaviour and metabolic capacity of cryopreserved human primary hepatocytes cultivated in a perfused multiwell device

References

• Allen JW, Bhatia SN. (2002). Improving the next generation of bioartificial liver devices. Semin Cell Dev Biol 13:447–54
   PubMed Web of Science ®Google Scholar
• Baker M. (2011). Tissue models: a living system on a chip. Nature 471:661–5
   PubMed Web of Science ®Google Scholar
• Baudoin R, Prot JM, Nicolas G, et al. (2013). Evaluation of seven drug metabolisms and clearances by cryopreserved human primary hepatocytes cultivated in microfluidic biochips. Xenobiotica 43:140–52
   PubMed Web of Science ®Google Scholar
• Bokhari M, Carnachan RJ, Cameron NR, Przyborski SA. (2007). Novel cell culture device enabling three-dimensional cell growth and improved cell function. Biochem Biophys Res Commun 354:1095–100
   PubMed Web of Science ®Google Scholar
• Chao P, Maguire T, Novik E, et al. (2009). Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human. Biochem Pharmacol 78:625–32
   PubMed Web of Science ®Google Scholar
• Dash A, Inman W, Hoffmaster K, et al. (2009). Liver tissue engineering in the evaluation of drug safety. Expert Opin Drug Metab Toxicol 5:1159–74
   PubMed Web of Science ®Google Scholar
• Domansky K, Inman W, Serdy J, Griffith L. (2005). Perfused microreactors for liver tissue engineering. Conf Proc IEEE Eng Med Biol Soc 7:7490–2
   PubMedGoogle Scholar
• Domansky K, Inman W, Serdy J, et al. (2010). Perfused multiwell plate for 3D liver tissue engineering. Lab Chip 10:51–8
   PubMed Web of Science ®Google Scholar
• Godoy P, Hewitt NJ, Albrecht U, et al. (2013). Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87:1315–30
   PubMed Web of Science ®Google Scholar
• Faucette SR, Hawke RL, Lecluyse EL, et al. (2000). Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metab Dispos 28:1222–30
   PubMed Web of Science ®Google Scholar
• Fiegel HC, Havers J, Kneser U, et al. (2004). Influence of flow conditions and matrix coatings on growth and differentiation of three-dimensionally cultured rat hepatocytes. Tissue Eng 10:165–74
   Google Scholar
• Hesse LM, Venkatakrishnan K, Court MH, et al. (2000). CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. Drug Metab Dispos 28:1176–83
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Lechón MJ, Houston JB, et al. (2007). Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39:159–234
   PubMed Web of Science ®Google Scholar
• Hoffmann SA, Müller-Vieira U, Biemel K, et al. (2012). Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studies. Biotechnol Bioeng 109:3172–81
   Google Scholar
• Huh D, Hamilton GA, Ingber DE. (2011). From 3D cell culture to organs-on-chips. Trends Cell Biol 21:745–54
   PubMed Web of Science ®Google Scholar
• Inamdar NK, Borenstein JT. (2011). Microfluidic cell culture models for tissue engineering. Curr Opin Biotechnol 22:681–9
   PubMed Web of Science ®Google Scholar
• Georgoff I, Secott T, Isom HC. (1984). Effect of simian virus 40 infection on albumin production by hepatocytes cultured in chemically defined medium and plated on collagen and non-collagen attachment surfaces. J Biol Chem 259:9595–602
   PubMedGoogle Scholar
• Kaihara S, Kim S, Kim BS, et al. (2000). Survival and function of rat hepatocytes cocultured with nonparenchymal cells or sinusoidal endothelial cells on biodegradable polymers under flow conditions. J Pediatr Surg 35:1287–90
   PubMed Web of Science ®Google Scholar
• Kratschmar DV, Messner S, Moritz W, Odermatt A. (2013). Characterization of a rat multi-cell type 3D-liver microtissue system. J Tissue Sci Eng 4:130–6
   Google Scholar
• Klieber S, Hugla S, Ngo R, et al. (2008). Contribution of the N-glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans. Drug Metab Dispos 36:851–62
   PubMed Web of Science ®Google Scholar
• LeCluyse EL, Witek RP, Andersen ME, Powers MJ. (2012). Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol 42:501–48
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT method. Methods 25:402–8
   PubMed Web of Science ®Google Scholar
• Lutz JD, Isoherranen N. (2012). Prediction of relative in vivo metabolite exposure from in vitro data using two model drugs: dextromethorphan and omeprazole. Drug Metab Dispos 40:159–68
   PubMed Web of Science ®Google Scholar
• Maguire TJ, Novik E, Chao P, et al. (2009). Design and application of microfluidic systems for in vitro pharmacokinetic evaluation of drug candidates. Curr Drug Metab 10:1192–9
   PubMed Web of Science ®Google Scholar
• Meng Q. (2010). Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 6:733–46
   PubMed Web of Science ®Google Scholar
• Messner S, Agarkova I, Moritz W, Kelm JM. (2013). Multi-cell type human liver microtissues for hepatotoxicity testing. Arch Toxicol 87:209–13
   PubMed Web of Science ®Google Scholar
• Meyer A, Vuorinen A, Zielinska AE, et al. (2013). Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1. Drug Metab Dispos 41:1671–8
   PubMed Web of Science ®Google Scholar
• Novik E, Maguire TJ, Chao P, et al. (2010). A microfluidic hepatic coculture platform for cell-based drug metabolism studies. Biochem Pharmacol 79:1036–44
   PubMed Web of Science ®Google Scholar
• Powers MJ, Janigian DM, Wack KE, et al. (2002). Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor. Tissue Eng 8:499–513
   PubMedGoogle Scholar
• Prot JM, Videau O, Brochot C, et al. (2011). A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening. Int J Pharm 408:67–75
   PubMed Web of Science ®Google Scholar
• Rodríguez-Antona C, Donato MT, Boobis A, et al. (2002). Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica 32:505–20
   PubMed Web of Science ®Google Scholar
• Sivaraman A, Leach JK, Townsend S, et al. (2005). A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr Drug Metab 6:569–91
   PubMed Web of Science ®Google Scholar
• Soldatow VY, Lecluyse EL, Griffith LG, Rusyn I. (2013). In vitro models for liver toxicity testing. Toxicol Res 2:23–39
   PubMed Web of Science ®Google Scholar
• Takashima T, Murase S, Iwasaki K, Shimida K. (2005). Evaluation of dextromethorphan metabolism using hepatocytes from CYP2D6 poor and extensive metabolizers. Drug Metab Pharmacokinet 20:177–82
   PubMedGoogle Scholar
• Vinci B, Duret C, Klieber S, et al. (2011). Modular bioreactor for primary human hepatocyte culture: medium flow stimulates expression and activity for detoxification genes. Biotechnol J 6:554–64
   PubMed Web of Science ®Google Scholar
• Wang S, Nagrath D, Chen PC, et al. (2008). Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue Eng 14:227–36
   Google Scholar
• Yeon JH, Na D, Park JK. (2010). Hepatotoxicity assay using human hepatocytes trapped in microholes of a microfluidic device. Electrophoresis 31:3167–74
   Google Scholar